Delivery Order SPE2DB24D1205-SPE2DB25FCTTP
- Not listed
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,425.95, is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has a period of performance through December 11, 2024 and uses a firm fixed-price pricing structure. This award is part of a larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm-fixed-price delivery order is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 11, 2025 and was awarded on March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ESBRIET 267 MG TABLET 270S. The contract is a Firm Fixed Price arrangement with a ceiling value of $3,425.95 and a completion date of July 30, 2025. This award is not set-aside and was issued as an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025 and was awarded on February 10, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price contract is for the delivery of ESBRIET 801 MG TABLET 90S, a medical product, with a period of performance through January 30, 2025. This order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. This contract does not have a set-aside designation, indicating it was awarded through open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $3,425.95, is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price contract with a performance period ending on March 3, 2025. The award date was February 7, 2025, and there was no set-aside designation used. AmerisourceBergen Drug Corp is the prime contractor,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price of $6,851.90 and a completion date of June 5, 2025. The contract is not set aside and was awarded on May 14, 2025. AmerisourceBergen Drug Corp is the prime contractor and holds a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $3,311.50, is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 12, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp, as...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the delivery of ESBRIET 267 MG TABLET 270S and has a completion date of July 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCTTPDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,703.80, is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 2/6/25 |